Benzinga | May 13, 2021 07:36AM EDT

Evaxion Biotech Q1 EPS $(0.23) Beats $(0.30) Estimate

Evaxion Biotech (NASDAQ:EVAX) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(0.30) by 23.33 percent.